These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 20848541

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Recommendations for the use of infliximab (Remicade) in Crohn's disease. GETECCU 2001].
    Domènech E, Esteve-Comas M, Gomollón F, Hinojosa J, Obrador A, Panés J, Gassull MA, Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU).
    Gastroenterol Hepatol; 2002 Mar; 25(3):162-9. PubMed ID: 11864540
    [No Abstract] [Full Text] [Related]

  • 26. [Long-term efficacy and predictors of response to infliximab in Korean patients with Crohn's disease].
    Lee KM.
    Korean J Gastroenterol; 2013 May; 61(5):241-5. PubMed ID: 23905245
    [No Abstract] [Full Text] [Related]

  • 27. [Adalimumab treatment in infliximab-resistant pediatric patient with Crohn's disease].
    Veres G, Putz R, Szabó D, Molnár K, Bodánszky H, Dezsofi A, Arató A.
    Orv Hetil; 2009 Oct 04; 150(40):1858-60. PubMed ID: 19789146
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Evidence for the clinical use of infliximab in Crohn's disease.
    Turner SM, Probert CS.
    Rom J Gastroenterol; 2003 Mar 04; 12(1):2-5. PubMed ID: 12673372
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Systemic amyloidosis with Crohn's disease treated with infliximab.
    Park YK, Han DS, Eun CS.
    Inflamm Bowel Dis; 2008 Mar 04; 14(3):431-2. PubMed ID: 17932971
    [No Abstract] [Full Text] [Related]

  • 32. [Infliximab in the treatment of Crohn's disease -- a practical approach. Infliximab and chronic Crohn's disease--Consensus statement of the Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH].
    Tilg H, Knoflach P, Petritsch W, Vogelsang H, Reinisch W, Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH.
    Z Gastroenterol; 2004 Oct 04; 42(10):1256-63. PubMed ID: 15508068
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Indications and results of infliximab in Crohn's disease].
    Karoui S, Boubaker J, Filali A.
    Tunis Med; 2004 Dec 04; 82(12):1057-63. PubMed ID: 15822505
    [Abstract] [Full Text] [Related]

  • 35. Infliximab in Crohn's disease-associated toxic megacolon.
    van Geenen EJ, Sachar DB.
    J Clin Gastroenterol; 2012 Apr 04; 46(4):321-3. PubMed ID: 21857531
    [Abstract] [Full Text] [Related]

  • 36. [Maintenance therapy with biologic agents for Crohn's disease: impact of scheduled maintenance therapy with infliximab].
    Endo K, Shiga H, Kakuta Y, Takahashi S, Kinouchi Y, Shimosegawa T.
    Nihon Shokakibyo Gakkai Zasshi; 2011 Mar 04; 108(3):401-9. PubMed ID: 21389661
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.